The European sleep-wake disorder market is estimated to grow at a CAGR of 5.5% during the forecast period. The key driving factor of the market in the region is the increasing sleep-wake disorders due to various behavioral health issues of the population which is expected to promote the demand for sleep-wake disorder treatment solutions, thereby promoting the growth of the market in the near future. According to the NCBI, about three-quarters of depressed patients have insomnia symptoms and hypersomnia. Moreover, there are various organizations that are promoting research on sleep disorders that further contributes to the market. For instance, The European Sleep Research Society is an international non-profit organization that promotes research on sleep and related areas, to improve the care for patients with sleep disorders and to facilitate the distribution of information regarding sleep medicine and sleep research.  

Europe consists of numerous key economies consisting of UK, Germany, Italy, Spain, and France among various others. The rest of Europe consists of countries such as Denmark, Belgium, Iceland, the Netherlands, Sweden, Russia and so on. The healthcare expenditure in these countries is also increasing yearly. The increase in the healthcare structure of these countries and the progressive government policies in the healthcare of these countries is focusing on the sleep-wake disorder treatment and research. The Swiss Society for Sleep Research, Sleep Medicine and Chronobiology (SSSSC) together include basic science and clinical sleep researchers, chronobiologists and sleep clinicians to promote and stimulate collaboration.

The market is segmented on the basis of type and treatment. Based on type, the market is sub-segmented into insomnia, hypersomnia, sleep apnea, circadian rhythm disorders, and others. Sleep apnea holds the largest market share during the forecast period. On the basis of treatment, the market is divide into therapies, drugs, and devices. The sleep-wake disorder devices segment is estimated to hold the largest market share during the forecast period, followed by medications.

Some of the players operating in the European sleep-wake disorder market include Koninklijke Philips N.V, Medtronic PLC, Sanofi SA, Jazz Pharmaceutical Inc., and others. In January 2019, Jazz Pharmaceuticals had received EU Marketing Authorization for SUNOSI (solriamfetol) for excessive daytime sleepiness in adults with narcolepsy or obstructive sleep apnea. The market authorization is anticipated to improve the availability of the drug in Europe.

Research Methodology

The market study of the European sleep-wake disorder market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for hospitals, sleep disorder device manufacturers, drug manufacturers, physicians, senior care centers, nursing centers, research organizations, investment companies, government organizations, regulatory authorities, and other market participants for the overall market and competitive analysis. The report provides an in-depth analysis of the market size and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions. 

Market Segmentation

1. European Sleep-Wake Disorder Market Research and Analysis by Type
2. European Sleep-Wake Disorder Market Research and Analysis by Treatment

The Report Covers

• Comprehensive research methodology of the European Sleep-Wake Disorder Market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the European Sleep-Wake Disorder Market.
• Insights about market determinants which are stimulating the European Sleep-Wake Disorder Market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.